M&A Deal Summary

T Capital Partners Acquires Showa Yakuhin Kako

On April 1, 2008, private equity firm T Capital Partners acquired life science company Showa Yakuhin Kako from CVC Capital Partners for 25.0B JPY

Acquisition Highlights
  • This is T Capital Partners’ 1st transaction in the Life Science sector.
  • This is T Capital Partners’ 0th largest (disclosed) transaction.
  • This is T Capital Partners’ 9th transaction in Japan.
Investment Fate
  • Showa Yakuhin Kako was sold to a consortium of financial buyers in 2011 for 905M USD.
  • Showa Yakuhin Kako was sold to a consortium of financial buyers in 2012.

M&A Deal Summary

Date 2008-04-01
Target Showa Yakuhin Kako
Sector Life Science
Buyer(s) T Capital Partners
Sellers(s) CVC Capital Partners
Deal Type Secondary Buyout
Deal Value 25.0B JPY

Target

Showa Yakuhin Kako

Tokyo, Japan
website
Showa Yakuhin Kako Co., Ltd. is a developer, manufacturer and distributor of medicines, dental drugs and medical equipments.

Search 175,694 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

T Capital Partners

Tokyo, Japan

website


Category Private Equity Firm
Founded 1991
PE ASSETS 1.2B USD
SizeLarge
Type Sector Agnostic
DESCRIPTION

T Capital Partners Co., Ltd. is a private equity firm focused on buyout and venture transactions in Japan. Within buyouts, the Firm looks to acquire controlling interests in established mid-cap companies with steady growth and strong market positions. T Capital will consider opportunities in a variety of sectors and generally partners with management when pursuing transactions. T Capital Partners was formed in 1991 and is based in Tokyo.


DEAL STATS #
Overall 9 of 18
Sector (Life Science) 1 of 2
Type (Secondary Buyout) 1 of 1
Country (Japan) 9 of 18
Year (2008) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-06 Sportsplex Japan

Tokyo, Japan

Sportsplex Japan Co., Ltd. is a provider of medical fitness clubs.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-01 MM Holdings

Tokyo, Japan

MM Holdings Co., Ltd. is an information processing platform for medical/healthcare entities. Data processing / EDI for medical claims.

Buy -

Seller(S) 1

SELLER

CVC Capital Partners

Luxembourg, Luxembourg

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1981
PE ASSETS 82.0B USD
SizeMega
Type Sector Agnostic
DESCRIPTION

CVC Capital Partners is a global private equity firm focused on investments in large companies located in Europe, North America, and Asia. CVC looks for opportunities with stable cash flows and talented management, and will consider businesses in a variety of industries. Target sectors include textiles, industrial products, waste management, building materials, energy/utilities, business services, financial services, distribution, healthcare, media, semiconductors, and gaming. CVC can handle transactions valued from €250 million to €10 billion. CVC Capital Partners was formed in 1981 and is based in Luxembourg.


DEAL STATS #
Overall 67 of 165
Sector (Life Science) 2 of 4
Type (Secondary Buyout) 17 of 41
Country (Japan) 1 of 7
Year (2008) 1 of 2
Size (of disclosed) 42 of 51
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-05 Stella Travel Services Group Pty

North Sydney, New South Wales, Australia

STS is an integrated distributor of travel product in Australasia, with around 7,000 staff in 12 countries and a network of 2,100 retail and corporate outlets under banners including Harvey World Travel, Travelscene American Express, Gullivers Travel, Transonic Travel, Travelbag and Global in the UK.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-18 Magnum

Kuala Lampur, Malaysia

Magnum is a gaming operator in Malaysia. The Company was the first private company to be granted a license to promote, operate and manage 4-digit numbers forecast betting in Malaysia. Magnum was founded in 1968 and is based in Kuala Lampur, Malaysia.

Buy $1.5B